Devices Orthopaedic Neurosurgery FDA

 News Release - October 18, 2011

Spineology Receives FDA Clearance for Rampart(TM) Interbody Fusion System

ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)-- Spineology Inc.,the innovator in anatomy-conserving spine surgery, announced today that it has received FDA clearance for, and is initiating launch of, the new Rampart™ line of Interbody fusion implants.

The Rampart line will include a variety of implant configurations, lengths and heights providing the surgeon with several options to fit patient needs. The Rampart System is further configured with implantation equipment designed to enhance the surgeon’s ability to position the implant within the disc space.

“Spineology is committed to developing the implant solutions our customers desire,” said John Booth, CEO for Spineology. “Rampart is a great synergistic fit for our growing product line.”

About Spineology Inc.

Spineology Inc., the innovator in anatomy-conserving spine surgery, develops spinal implants and instruments. Spineology surgical techniques conserve spinal bone, ligament and muscle tissue. Spineology is committed to increasing procedural efficiency, reducing surgical morbidity and accelerating patient recovery. Learn more at Spineology.com.

Source: Spineology

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.